About
Technology
Issues
FAQ
Links
Official Page
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.